A trial to evaluate the safety and immunogenicity of a helper peptide vaccine plus combination of BRAF inhibition and MEK inhibition (Mel61)

IRB/UVA Tracking #
17700
Contact
Adela Mahmutovic
Contact Email
Contact Phone
Phase
I/II
Primary purpose
Treatment
Cancer PI
Elizabeth M Gaughan
Status
OPEN TO ACCRUAL
Ages
Adult